Mettler-Toledo Return on Tangible Equity 2010-2025 | MTD
Current and historical return on tangible equity values for Mettler-Toledo (MTD) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Mettler-Toledo Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $0.85B | $-1.11B | -78.43% |
| 2024-12-31 | $0.86B | $-1.05B | -79.87% |
| 2024-09-30 | $0.80B | $-1.09B | -72.80% |
| 2024-06-30 | $0.79B | $-1.09B | -72.47% |
| 2024-03-31 | $0.78B | $-1.10B | -72.35% |
| 2023-12-31 | $0.79B | $-1.11B | -75.25% |
| 2023-09-30 | $0.87B | $-1.05B | -86.35% |
| 2023-06-30 | $0.89B | $-1.05B | -89.08% |
| 2023-03-31 | $0.89B | $-0.99B | -91.49% |
| 2022-12-31 | $0.87B | $-0.94B | -92.80% |
| 2022-09-30 | $0.84B | $-1.02B | -92.93% |
| 2022-06-30 | $0.82B | $-0.94B | -97.74% |
| 2022-03-31 | $0.79B | $-0.87B | -100.22% |
| 2021-12-31 | $0.77B | $-0.79B | -101.48% |
| 2021-09-30 | $0.76B | $-0.77B | -111.27% |
| 2021-06-30 | $0.71B | $-0.74B | -127.15% |
| 2021-03-31 | $0.66B | $-0.74B | -146.45% |
| 2020-12-31 | $0.60B | $-0.46B | -162.10% |
| 2020-09-30 | $0.58B | $-0.30B | -172.49% |
| 2020-06-30 | $0.55B | $-0.29B | -162.19% |
| 2020-03-31 | $0.55B | $-0.44B | -168.18% |
| 2019-12-31 | $0.56B | $-0.32B | -213.11% |
| 2019-09-30 | $0.55B | $-0.30B | -245.64% |
| 2019-06-30 | $0.55B | $-0.24B | -267.16% |
| 2019-03-31 | $0.53B | $-0.19B | -265.17% |
| 2018-12-31 | $0.51B | $-0.16B | -249.15% |
| 2018-09-30 | $0.41B | $-0.23B | -185.67% |
| 2018-06-30 | $0.39B | $-0.22B | -170.23% |
| 2018-03-31 | $0.38B | $-0.21B | -173.53% |
| 2017-12-31 | $0.38B | $-0.22B | -174.07% |
| 2017-09-30 | $0.44B | $-0.26B | -204.92% |
| 2017-06-30 | $0.43B | $-0.19B | -231.24% |
| 2017-03-31 | $0.41B | $-0.20B | -261.37% |
| 2016-12-31 | $0.39B | $-0.21B | -345.29% |
| 2016-09-30 | $0.37B | $-0.15B | -675.80% |
| 2016-06-30 | $0.36B | $-0.07B | -3254.55% |
| 2016-03-31 | $0.36B | $-0.02B | 1148.39% |
| 2015-12-31 | $0.35B | $0.02B | 536.88% |
| 2015-09-30 | $0.35B | $0.02B | 344.96% |
| 2015-06-30 | $0.35B | $0.10B | 206.86% |
| 2015-03-31 | $0.34B | $0.12B | 151.60% |
| 2014-12-31 | $0.34B | $0.16B | 118.49% |
| 2014-09-30 | $0.33B | $0.29B | 97.39% |
| 2014-06-30 | $0.32B | $0.34B | 94.54% |
| 2014-03-31 | $0.31B | $0.35B | 99.52% |
| 2013-12-31 | $0.31B | $0.37B | 107.84% |
| 2013-09-30 | $0.30B | $0.28B | 117.23% |
| 2013-06-30 | $0.30B | $0.25B | 122.79% |
| 2013-03-31 | $0.29B | $0.24B | 124.92% |
| 2012-12-31 | $0.29B | $0.26B | 125.03% |
| 2012-09-30 | $0.28B | $0.23B | 126.41% |
| 2012-06-30 | $0.28B | $0.21B | 122.67% |
| 2012-03-31 | $0.27B | $0.24B | 113.34% |
| 2011-12-31 | $0.27B | $0.21B | 111.62% |
| 2011-09-30 | $0.26B | $0.24B | 103.96% |
| 2011-06-30 | $0.25B | $0.28B | 106.04% |
| 2011-03-31 | $0.24B | $0.23B | 115.17% |
| 2010-12-31 | $0.23B | $0.23B | 121.15% |
| 2010-09-30 | $0.22B | $0.20B | 126.07% |
| 2010-06-30 | $0.20B | $0.17B | 128.62% |
| 2010-03-31 | $0.18B | $0.16B | 136.94% |
| 2009-12-31 | $0.17B | $0.17B | 191.69% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $25.284B | $3.872B |
| Mettler-Toledo International Inc. is the world's largest manufacturer and marketer of weighing instruments for use in laboratory, industrial and food retailing applications. The company focuses on the high value-added segments of the weighing instruments market by providing solutions for specific applications. Mettler-Toledo is also a leading provider of analytical instruments for use in life science, reaction engineering and real-time analytic systems used in drug and chemical compound development, and process analytics instruments used for in-line measurement in production processes. The company has three reportable segments: Laboratory Instruments, Industrial Instruments and Retail Weighing Solutions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $189.818B | 83.14 |
| Thermo Fisher Scientific (TMO) | United States | $156.486B | 18.93 |
| Edwards Lifesciences (EW) | United States | $44.464B | 29.15 |
| Alcon (ALC) | Switzerland | $43.874B | 29.65 |
| IDEXX Laboratories (IDXX) | United States | $42.296B | 48.61 |
| DexCom (DXCM) | United States | $33.259B | 51.41 |
| IQVIA Holdings (IQV) | United States | $27.640B | 15.48 |
| STERIS (STE) | Ireland | $23.842B | 26.26 |
| Waters (WAT) | United States | $20.819B | 29.37 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.720B | 0.00 |
| Hologic (HOLX) | United States | $14.516B | 15.77 |
| Sysmex ADR (SSMXY) | Japan | $10.481B | 29.73 |
| Penumbra (PEN) | United States | $9.903B | 77.73 |
| Masimo (MASI) | United States | $9.110B | 33.61 |
| Globus Medical (GMED) | United States | $8.322B | 19.83 |
| Teleflex (TFX) | United States | $5.543B | 9.15 |
| Glaukos (GKOS) | United States | $5.465B | 0.00 |
| TransMedics (TMDX) | United States | $4.764B | 103.57 |
| Integer Holdings (ITGR) | United States | $4.275B | 22.40 |
| PROCEPT BioRobotics (PRCT) | United States | $3.554B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.595B | 15.45 |
| Veracyte (VCYT) | United States | $2.183B | 30.64 |
| Nihon Kohden (NHNKY) | Japan | $2.111B | 24.21 |
| Elekta AB (EKTAY) | Sweden | $1.910B | 17.17 |
| Alphatec Holdings (ATEC) | United States | $1.785B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.495B | 0.00 |
| Artivion (AORT) | United States | $1.249B | 116.96 |
| Pulse Biosciences (PLSE) | United States | $1.167B | 0.00 |
| OPKO Health (OPK) | United States | $1.094B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.086B | 5.78 |
| Beta Bionics (BBNX) | United States | $0.835B | 0.00 |
| SiBone (SIBN) | United States | $0.814B | 0.00 |
| IRadimed (IRMD) | United States | $0.762B | 38.67 |
| RxSight (RXST) | United States | $0.638B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.597B | 9.29 |
| Mesa Laboratories (MLAB) | United States | $0.569B | 13.34 |
| Delcath Systems (DCTH) | United States | $0.565B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.538B | 0.00 |
| AxoGen (AXGN) | United States | $0.486B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.453B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.452B | 0.00 |
| NeuroPace (NPCE) | United States | $0.424B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.388B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.372B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.351B | 9.35 |
| Pacific Biosciences Of California (PACB) | United States | $0.348B | 0.00 |
| 908 Devices (MASS) | United States | $0.255B | 0.00 |
| Neuronetics (STIM) | United States | $0.249B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.241B | 14.58 |
| Alpha Tau Medical (DRTS) | Israel | $0.217B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.216B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.193B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.182B | 0.00 |
| Inogen (INGN) | United States | $0.178B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| CVRx (CVRX) | United States | $0.170B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.157B | 0.00 |
| LENSAR (LNSR) | United States | $0.152B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.141B | 0.00 |
| Accuray (ARAY) | United States | $0.132B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.114B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.096B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.095B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.084B | 51.30 |
| EnVVeno Medical (NVNO) | United States | $0.076B | 0.00 |
| InspireMD (NSPR) | United States | $0.075B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.062B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.027B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.37 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |